Alkermes
ALKS
#2324
Rank
HK$61.75 B
Marketcap
HK$367.51
Share price
3.08%
Change (1 day)
61.36%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): -HK$0.01654

According to Alkermes's latest financial reports the company's current EPS (TTM) is -HK$0.0000000000. In 2025 the company made an earnings per share (EPS) of HK$11.53 a decrease over its 2024 EPS that were of HK$17.49.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$0.01654-100.14%
2025HK$11.53-34.08%
2024HK$17.493.72%
2023HK$16.87-323.96%
2022-HK$7.53220%
2021-HK$2.35-57.19%
2020-HK$5.50-44.38%
2019-HK$9.88
2017-HK$8.08-24.82%
2016-HK$10.75-9.87%
2015-HK$11.92660%
2014-HK$1.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.40-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.18-9,457,550,908,645,462,016.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54-3,567,802,533,542,780,416.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.46-8,142,500,972,776,665,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.85-12,826,240,470,391,560,192.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-HK$394.65 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$3.53-810,647,220,741,039,744.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel